{"url_path":"/sec/artl/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1621221/0001640334-26-000869-index.html","accession_number":"0001640334-26-000869","cik":"0001621221","ticker":"ARTL","issuer_name":"ARTELO BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1621221/0001640334-26-000869-index.html","primary_entity_key":"0001621221","primary_entity_name":"ARTELO BIOSCIENCES, INC."},"word_count":40,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**\n\n \n\nThere were no sales of unregistered securities by us during the three months ended March 31, 2026 that were not previously disclosed in a Current Report on Form 8-K."}